Hum. Reprod. Advance Access originally published online on October 6, 2005
Human Reproduction 2006 21(1):193-201; doi:10.1093/humrep/dei272
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential effects of inducers of syncytialization and apoptosis on BeWo and JEG-3 choriocarcinoma cells
1 Department of Obstetrics and Gynaecology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
2 To whom correspondence should be addressed: e-mail: salwan.al-nasiry{at}med.kuleuven.ac.be
BACKGROUND: The interactions of trophoblasts with the cytokine network at the fetomaternal interface determine the pathway the cell undertakes, e.g. proliferation, differentiation and apoptosis. METHODS: We used cultures of fusigenic BeWo and non-fusigenic JEG-3 choriocarcinoma cells to study the effects of inducers of syncytialisation (forskolin) and apoptosis [tumour necrosis factor-
(TNF)] on differentiation, viability, proliferation and apoptosis. RESULTS: E-cadherin immunostaining showed that syncytium formation was confined to BeWo and not JEG-3 cells, while secretion of hCG was promoted by forskolin in both cell types implying a ‘dissociation’ between morphological and biochemical differentiation. Forskolin also had differential effects on cell viability (MTT reduction test) and proliferation (Ki67 immunostaining with MIB-1 monoclonal antibody), both decreasing in BeWo and increasing in JEG-3 cells. TNF increased apoptosis (cytokeratin neo-epitope immunostaining with M30 monoclonal antibody) in both cell types, an effect which was blocked by epidermal growth factor selectively in JEG-3 cells. CONCLUSION: Our results suggest that the differential responses of BeWo and JEG-3 cells to inducers of syncytialization and apoptosis might be related to their fusigenic capacity. Caution is needed when extrapolating results obtained by these models to normal trophoblast populations. However, we speculate that these models can help identify key factors involved in trophoblast differentiation at the placental bed.
Key words:
choriocarcinoma/differentiation/EGF/orskolin/TNF
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Robinson, W. E. Ackerman IV, N. J. Behrendt, and D. D. Vandre While Dysferlin and Myoferlin Are Coexpressed in the Human Placenta, Only Dysferlin Expression Is Responsive to Trophoblast Fusion in Model Systems Biol Reprod, July 1, 2009; 81(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Benaitreau, M.-N. Dieudonne, E. D. Santos, M.-C. Leneveu, P. d. Mazancourt, and R. Pecquery Antiproliferative Effects of Adiponectin on Human Trophoblastic Cell Lines JEG-3 and BeWo Biol Reprod, June 1, 2009; 80(6): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Orozco, C. J. Jorgez, C. Horne, D. A. Marquez-Do, M. R. Chapman, J. R. Rodgers, F. Z. Bischoff, and D. E. Lewis Membrane Protected Apoptotic Trophoblast Microparticles Contain Nucleic Acids: Relevance to Preeclampsia Am. J. Pathol., December 1, 2008; 173(6): 1595 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. U. Baumann, S. Zamudio, and N. P. Illsley Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1 Am J Physiol Cell Physiol, July 1, 2007; 293(1): C477 - C485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Al-Nasiry, N. Geusens, M. Hanssens, C. Luyten, and R. Pijnenborg The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells Hum. Reprod., May 1, 2007; 22(5): 1304 - 1309. [Abstract] [Full Text] [PDF]
|
|